Rumalaya forte tablets fortify Himalaya’s presence in arthritis control
EHM Team - Bangalore
Himalaya, pioneer in herbal healthcare and producer of the popular Liv 52 has strengthened its presence in the anti-rheumatic, anti-inflammatory market with the launch of Rumalaya forte in January this year. The existing brands of Himalaya such as Rumalaya tablets and Rumalaya cream are well accepted by the medical fraternity for arthritis and other painful inflammatory disorders of muscles and joints.
Arthritis and inflammatory disorders of muscles and joints account for more than 31.5 crore outpatient visits every year worldwide and these disorders result in symptoms like pain, swelling, stiffness, restricted mobility of joints and lead to deterioration in the quality of life. Arthritis erodes the capability to perform basic functions, prevents the person from participating in daily routine activities and can cause emotional and socio-economic problems.
Unfortunately, current therapies such as NSAIDs are less than ideal as most of the NSAIDs are known to cause gastric irritation, gastrointestinal ulceration, reduced renal blood flow, platelet dysfunction and exacerbation of asthma, allergic reactions and skin rashes. Hence, these drugs are not recommended for long-term administration. Though the newer NSAIDs are considered to be safer, they have limitation in terms of cost of therapy, which is beyond the reach of common people.
Present therapies present a lot of side effects and then there is also the concern about escalating costs. “For this niche, Himalaya developed an effective, safe and cost effective medicine for better arthritis control. These aspects are very important for patients who do not tolerate NSAIDs and are high-risk patients,” said Philipe Haydon GM-Pharma Marketing.
Rumalaya forte is specially formulated for long-term use in arthritis and other painful inflammatory disorders affecting muscles and joints. Rumalaya forte is an effective and safe alternative to other anti-inflammatory drugs. Rumalaya forte is a potent herbomineral formulation with the dual advantage of Shallaki and Guggulu. Rumalaya forte provides better arthritis control, and thus improves the quality of life in arthritic patients. Shallaki and Guggulu are well known in medical and scientific communities across the world for their proven efficacy in joint care. Shallaki (Boswellia serrata) present in Rumalaya forte is approved by the FDA and Council of Europe. Guduchi in Rumalaya forte is well known for its immunomodulatory activity. Rumalaya forte also contains Rasna, Yashti-madhu and Gokshura. Clinical trials have proven the effectiveness and safety of Rumalaya forte. Rumalaya forte exerts potent immunomodulatory, anti-inflammatory analgesic actions, and thereby reduces joint swelling, relieves pain and improves joint mobility. The market for anti-rheumatic, ani-inflammatory and analgesic preparations is huge and NSAIDs form the largest segment of this market.
The NSAIDs market is estimated to be around Rs 800 crore and growing at 14 per cent annually (Source: ORG MARG data of November 2001). An interesting fact is that, this market for anti-rheumatic, anti-inflammatory and analgesic preparations contributes around five per cent to the total pharma market. Rumalaya forte comes with a twice-daily dose and is available in a convenient monthly dose pack of 60 tablets (2 strips of 30s), the cost of which is Rs 90. Himalaya with its excellent market coverage and penetration aims to strengthen its position in the vast anti-rheumatic, anti-inflammatory & analgesic preparations market, with the launch of Rumalaya forte tablets.
http://www.expresshealthcaremgmt.com/20020228/international4.shtml
